Magnesium-L-Threonate Improves Menopausal Symptoms

This trial has a randomized, single-blind, single-center, parallel-controlled design, with participant screening and trial implementation conducted at Guangdong Provincial People's Hospital. The study evaluate the efficacy of oral magnesium L-threonate supplementation on improving menopausal symptoms and quality of life among peri/post-menopausal women. This trial aims to explore whether oral magnesium L-threonate supplementation could alleviate menopausal syndromes. Participants will randomly assigned to conduct oral magnesium L-threonate supplementation or placebo for 8 weeks. Face-to-face and internet follow up will be conducted once per 2 weeks.

NCT Number	NCT06959745
Lead Sponsor	Guangdong Provincial People's Hospital
Conditions	Menopause Syndrome, Magnesium
Enrollment	50 participants
Start Date	2025-05-15
Primary Completion	2025-09-30 (estimated)
Study Completion	2025-12-30 (estimated)
Updated on ClinicalTrials.gov	2025-05-07